Immunic Therapeutics

Immunic Therapeutics is a clinical-stage biotechnology company that specializes in the development of orally-administered, small-molecule therapies for chronic inflammatory and autoimmune diseases. They have a focus on developing treatments for multiple sclerosis, celiac disease, and other gastrointestinal conditions. Their lead development program is vidofludimus calcium (IMU-838), which is currently in Phase 3 and Phase 2 clinical trials for relapsing and progressive multiple sclerosis, respectively. They are also developing IMU-856, a treatment for celiac disease, which has shown promising results in early clinical trials.

Immunic is committed to developing innovative therapies that address the unmet needs of patients with chronic inflammatory and autoimmune diseases. They are driven by a passion for science and a belief that their research can make a real difference in the lives of patients. Their company values include empowerment, action, respect, and a love for the beauty of science. They believe in making smart decisions and taking calculated risks in order to achieve their goals.

Immunic Therapeutics is a biotechnology company dedicated to developing novel, orally administered, small-molecule therapies for chronic inflammatory and autoimmune diseases. Their mission is to address unmet medical needs by creating high-quality treatment options with comprehensive therapeutic efficacy and outstanding safety and tolerability, ultimately improving the lives of patients suffering from these debilitating conditions.

Immunic Therapeutics cultivates a culture of respect, collaboration, and dedication to scientific excellence. They empower their employees to take ownership of their responsibilities and support their growth, both personally and professionally. The company embraces a sense of urgency and smart pragmatism, while prioritizing the pursuit of innovative treatment options for patients suffering from debilitating diseases.

Immunic Therapeutics emphasizes the importance of diversity, equity and inclusion, recognizing that a diverse workforce is crucial to driving innovation and creating a workplace where everyone feels valued and respected. The company fosters a culture of respect and appreciation, supporting individuals and teams with the resources they need to succeed. This includes empowering employees to grow with their responsibilities, making smart decisions, and taking calculated risks in a safe environment. By prioritizing a culture of inclusion, Immunic strives to attract and retain a diverse workforce, creating a dynamic and collaborative environment that benefits both employees and patients.